Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinically relevant interpretation of genotype for resistance to abacavir.

AIDS (London, England) - 15 Aug 2003

Brun-Vézinet Françoise, Descamps Diane, Ruffault Annick, Masquelier Bernard, Calvez Vincent, Peytavin Gilles, Telles Fabienne, Morand-Joubert Laurence, Meynard Jean-Luc, Vray Muriel, Costagliola Dominique

Abstract excerpt

OBJECTIVE: To develop a stepwise methodology for the development and validation of clinically relevant genotypic score for resistance to antiretroviral drugs and to apply this approach to the genotypic resistance to abacavir. METHODS: All patients having received abacavir during the Narval trial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Dideoxynucleosides
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Multivariate Analysis

Share to Reverse Transcriptase Inhibitors

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 12891065
DOI: 10.1097/00002030-200308150-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12891065-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinically relevant interpretation of genotype for resistance to abacavir.PMID 12891065Read ↗

Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients.Semantic proximity Read ↗

A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.Semantic proximity Read ↗

Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.Semantic proximity Read ↗

Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data.Semantic proximity Read ↗

Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response.Semantic proximity Read ↗

Simple algorithm derived from a geno-/phenotypic database to predict HIV-1 protease inhibitor resistance.Semantic proximity Read ↗

Decoding HIV resistance: from genotype to therapy.Semantic proximity Read ↗

Prediction of abacavir resistance from genotypic data: impact of zidovudine and lamivudine resistance in vitro and in vivo.Semantic proximity Read ↗

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.Semantic proximity Read ↗

Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients.Semantic proximity Read ↗

Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling.Semantic proximity Read ↗

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.